Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Merck & Co., Inc.

03:44 EST 18th February 2019 | BioPortfolio

Here are the most relevant search results for "Merck & Co., Inc." found in our extensive news archives from over 250 global news sources.

More Information about Merck & Co., Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Merck & Co., Inc. for you to read. Along with our medical data and news we also list Merck & Co., Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Merck & Co., Inc. Companies for you to search.

Showing News Articles 1–25 of 354 from Merck & Co., Inc.

Saturday 16th February 2019

That's a wrap on #GU19, but our commitment to #InventingForLife continues every single day. See you in June for more discussions on #cancer care at #ASCO19!pic.twitter.com/8mHlYYGSAT

That's a wrap on #GU19, but our commitment to #InventingForLife continues every single day. See you in June for more discussions on #cancer care at #ASCO19! pic.twitter.com/8mHlYYGSAT

Before After: Packed #GU19 session as inventors + researchers gather to hear the newest #kidneycancer data.pic.twitter.com/jc9yG8IM9i

Before After: Packed #GU19 session as inventors + researchers gather to hear the newest #kidneycancer data. pic.twitter.com/jc9yG8IM9i

Learn more about our work in #kidneycancer: http://bit.ly/2IbsyGb  #GU19pic.twitter.com/qYzmPC3O7Z

Learn more about our work in #kidneycancer: http://bit.ly/2IbsyGb  #GU19 pic.twitter.com/qYzmPC3O7Z

Heading up to the next session to discuss exciting advancements in #kidneycancer. #GU19pic.twitter.com/BtyNaUcplY

Heading up to the next session to discuss exciting advancements in #kidneycancer. #GU19 pic.twitter.com/BtyNaUcplY

Heading up the next session to discuss exciting #kidneycancer research. #GU19pic.twitter.com/s8FdvJ7DDZ

Heading up the next session to discuss exciting #kidneycancer research. #GU19 pic.twitter.com/s8FdvJ7DDZ

Friday 15th February 2019

We're collaborating to make a difference in the lives of people with #cancer. Meet our team who is committed to our mission of #InventingForLife: https://bit.ly/2WYeT8U  #GU19pic.twitter.com/P8gC0JyB3v

We're collaborating to make a difference in the lives of people with #cancer. Meet our team who is committed to our mission of #InventingForLife: https://bit.ly/2WYeT8U  #GU19 pic.twitter.com/P8gC0JyB3v

Despite new discoveries in #bladdercancer research, there is still a need for scientific advancement. Watch as our team shares what drives them to address this need. http://bit.ly/2tn18mm  #InventingForLife #GU19pic.twitter.com/GHkIhX9dA5

Despite new discoveries in #bladdercancer research, there is still a need for scientific advancement. Watch as our team shares what drives them to address this need. http://bit.ly/2tn18mm  #InventingForLife #GU19 pic.twitter.com/GHkIhX9dA5

Busy day two at @ASCO #GU19! Ready to discuss the newest advancements in #bladdercancer.pic.twitter.com/JhqKFVi6on

Busy day two at @ASCO #GU19! Ready to discuss the newest advancements in #bladdercancer. pic.twitter.com/JhqKFVi6on

Proud to share our latest #oncology news in #kidneycancer. More data to be presented at @ASCO #GU19: http://bit.ly/2BGosA9  $MRKpic.twitter.com/ZE1PFH4qZs

Proud to share our latest #oncology news in #kidneycancer. More data to be presented at @ASCO #GU19: http://bit.ly/2BGosA9  $MRK pic.twitter.com/ZE1PFH4qZs

Thursday 14th February 2019

Thanks for voting! The answer is D (based on 2012 data from the World Health Organization). #ProstateCancer #GU19pic.twitter.com/y7gNlXM4ay

Thanks for voting! The answer is D (based on 2012 data from the World Health Organization). #ProstateCancer #GU19 pic.twitter.com/y7gNlXM4ay

Full session at @ASCO #GU19 discussing the latest advancements in #prostatecancer.pic.twitter.com/mysmEf78bA

Full session at @ASCO #GU19 discussing the latest advancements in #prostatecancer. pic.twitter.com/mysmEf78bA

#GU19 Quiz: Some of the most common risk factors for #prostatecancer include:

#GU19 Quiz: Some of the most common risk factors for #prostatecancer include:

We’re excited to join scientists and researchers to discuss the latest advancements in #cancer care during day one at @ASCO #GU19!pic.twitter.com/mW5HaAXmvQ

We’re excited to join scientists and researchers to discuss the latest advancements in #cancer care during day one at @ASCO #GU19! pic.twitter.com/mW5HaAXmvQ

Almost everyone knows somebody living with #prostatecancer. We’re aggressively building our prostate cancer research program: http://bit.ly/2I7q1g6  #GU19pic.twitter.com/8TIjvri1KA

Almost everyone knows somebody living with #prostatecancer. We’re aggressively building our prostate cancer research program: http://bit.ly/2I7q1g6  #GU19 pic.twitter.com/8TIjvri1KA

Click here to read our latest #prostatecancer news: https://bit.ly/2tnbmmY  #GU19 $MRKpic.twitter.com/QaW70jgKxo

Click here to read our latest #prostatecancer news: https://bit.ly/2tnbmmY  #GU19 $MRK pic.twitter.com/QaW70jgKxo

Wednesday 13th February 2019

.@ASCO #GU19 is almost here. Looking forward to hearing the latest #oncology updates in San Francisco!pic.twitter.com/zQXXA76gxm

. @ASCO #GU19 is almost here. Looking forward to hearing the latest #oncology updates in San Francisco! pic.twitter.com/zQXXA76gxm

Nothing inspires James Fells more than logic puzzles and word problems. Can you guess his job at Merck? Clue: Fells solves similar kinds of puzzles in the lab: chemical tests. See the role James plays in our mission of #InventingForLife: http://bit.ly/2G

Nothing inspires James Fells more than logic puzzles and word problems. Can you guess his job at Merck? Clue: Fells solves similar kinds of puzzles in the lab: chemical tests. See the role James plays in our mission of #InventingForLife: http://bit.ly/2Gzt26m  #BlackHistoryMonth

Tuesday 12th February 2019

For more than 30 years, we have been committed to #HIV research and discovery. We’re continuing the fight against HIV-1 for people like Catherine. Learn about her story here: http://bit.ly/2E7Ki17 pic.twitter.com/DwrXXGoEP5

For more than 30 years, we have been committed to #HIV research and discovery. We’re continuing the fight against HIV-1 for people like Catherine. Learn about her story here: http://bit.ly/2E7Ki17  pic.twitter.com/DwrXXGoEP5

Monday 11th February 2019

Click here to see #immunooncology research to be presented at @ASCO #GU19: https://bit.ly/2tg9R9Z  $MRKpic.twitter.com/pfSk2aHMxT

Click here to see #immunooncology research to be presented at @ASCO #GU19: https://bit.ly/2tg9R9Z  $MRK pic.twitter.com/pfSk2aHMxT

Scientists Inventors Leaders - a hopeful future starts with championing women to reach their full potential. Learn more about #WomenInScience here: http://bit.ly/2WVYNfN pic.twitter.com/WMP1ungULE

Scientists Inventors Leaders - a hopeful future starts with championing women to reach their full potential. Learn more about #WomenInScience here:

Click here to read our latest #oncology news in head and neck cancer: https://bit.ly/2tgbjcp  $MRK

Click here to read our latest #oncology news in head and neck cancer: https://bit.ly/2tgbjcp  $MRK

Friday 8th February 2019

1 in 4 people living with #HIV around the world were unaware of their status.pic.twitter.com/QxeEZDkcUc

1 in 4 people living with #HIV around the world were unaware of their status. pic.twitter.com/QxeEZDkcUc

Thursday 7th February 2019

This #BlackHistoryMonth, Brandon Atkins is honored to carry on the legacy of his father, who overcame growing up in the Jim Crow South to become a successful cardiologist, dean, and coach. Learn more in his video. #AtMerckImInspired #PoweredByInclusionpic

This #BlackHistoryMonth , Brandon Atkins is honored to carry on the legacy of his father, who overcame growing up in the Jim Crow South to become a successful cardiologist, dean, and coach. Learn more in his video. #AtMerckImInspired #PoweredByInclusion

Wednesday 6th February 2019

Hello, Florida! We’re thrilled to be joining physicians from across the country at #PriMedSouth.pic.twitter.com/cIs1YRFOn0

Hello, Florida! We’re thrilled to be joining physicians from across the country at #PriMedSouth. pic.twitter.com/cIs1YRFOn0

#DYK about 1/3 of adults diagnosed with #diabetes are not at their A1C goal? #FocusonA1C

#DYK about 1/3 of adults diagnosed with #diabetes are not at their A1C goal? #FocusonA1C


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks